Table 2 Karyotype Based on Spectral Karyotyping and G-banding, and CGH Results of the Cell Line L56Br-Cl

From: Characterization of a Novel Breast Carcinoma Xenograft and Cell Line Derived from a BRCA1 Germ-Line Mutation Carrier

Karyotype

Losses

Gains

63–66〈3n〉, X, der(X)t(X;4)(q26;q24)x1–2, der(X)t(X;6), der(1)t(6;1;6;3), der(1)t(1;6;3), der(1)(3;6;1;6;3;6), der(2)t(3;2;14), der(2)t(2;3)(p23;p2?), der(2)t(22;2;8)x1–2, t(3;3)(p13–14;q27–29), der(3)t(3;17)(q12;q23), −4, der(4)t(4;11)(q31;q13), der(4)t(4;11;3), −5, −6, der(7)t(7;8), der(7)t(7;15)x1–2, der(8)t(8;6;X), der(8)t(7;8), der(8)t(2;8), der(10)t(3;10), −11, −12, der(12)t(12;15)(p11;q15)x2, −13, del(13q?)x2, der(14)t(5;14)x2, der(14)t(2;14), −15, −15, del(15q?), −16, inv(16)(p13q22)x2, −17, der(18)(6;18)x2, +18 der(19)t(9;19;5;11), der(19)t(19;16)x2, +20, −21, −22, der(22)t(12;22)(?;q12)x2 [cp15]

1p31-pter, 2p23-pter, 2q, 4p, 4q21, 6p, 6q24-qter, 7q22-qter, 8p, 10q22-qter, 11c-p13, 12, 15, 16p, 17pter-q21, 19, 21, 22

Xq26-qter, 2c-p21, 3p21.3-pter, 3q, 4q26-qter, 5p, 5q14, q22, 6q22–q23, 7p13-pter, 8q22-qter, 9p, 10p, 11q13–14, 13q21.2-qter, 14c-q22, 17q22-qter, 18, 20pter-q12

Back to article page